Anti-viral activity of Withania somnifera phytoconstituents against corona virus (SARS-COV-2)

  • Shweta Parihar Research scholar Maharishi Dayanand university Rohtak
Keywords: Withania somnifera, Anti-viral, COVID-19 herb, Solanaceae, Phytochemicals

Abstract

Introduction: Traditional medicine practitioners use natural active compounds found in medicinal plants to treat a variety of diseases. Withania somnifera, also known as Ashwagandha, Winter Cherry, and Indian Ginseng, is one such herb that has been used to cure a variety of ailments since the time of Ayurveda, India's ancient medical system. The Solanaceae family includes Withania somnifera.

Method: The exhaustive literature survey has been done via various search engines, review articles, research articles, google scholar, PubMed, internet. According to recent investigations, Withanolides, a bioactive ingredient of Withania somnifera, have shown therapeutic efficacy in decreasing the intensity of SARS-CoV-2 and in providing medical care and attention to individuals suffering from COVID-19. Free-radical scavenging is another feature of Ashwagandha. This review article contains information regarding phytochemistry and antiviral activity against coronavirus.

Results: In-silico investigations have revealed that it has a high binding affinity for the ACE2–RBD interface, which could prevent SARS COV 2 from infecting cells. In India, ashwagandha is available as a liquid, tablet, or powder. This review article's aim is to provide all the information and research work that should be done by researchers recently against SARS COVID-19.

Discussion: Due to its immune-modulatory, anti-stress, and antiviral characteristics, Ashwagandha has been chosen. The aim of the review article is to review ‘the anti-viral activity of Withania somnifera phytoconstituents against coronavirus (SARS-COV-2).

Downloads

Download data is not yet available.

References

Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., & Bouachrine, M. (2021). Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of biomolecular structure & dynamics, 39(8), 2971–2979.

Balkrishna, A., Pokhrel, S., Singh, H., Joshi, M., Mulay, V. P., Haldar, S., & Varshney, A. (2021). Withanone from Withania somniferaAttenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model. Drug design, development and therapy, 15, 1111–1133.

Chaudhary, K., Parihar, S., Sharma, D. (2021). A Critical Review on Nanoscience Advancement: In Treatment of Viral Infection. Journal of Drug Delivery and Therapeutics 11 (6), 225-237.

Chaurasiya, N. D., Gupta, V. K., Sangwan, R. S. (2007) Leaf ontogenic phase related dynamics of withaferin A and withanone biogenesis in Ashwagandha (Withania somnifera) – an important medicinal herb. J Plant Biol., 50, 508–513.

Chikhale, R. V., Gurav, S. S., Patil, R. B., Sinha, S. K., Prasad, S. K., Shakya, A., Shrivastava, S. K., Gurav, N. S., & Prasad, R. S. (2021). Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. Journal of biomolecular structure & dynamics, 39(12), 4510–4521.

Dar, N. J., Hamid, A., & Ahmad, M. (2015). Pharmacologic overview of Withaniasomnifera, the Indian Ginseng. Cellular and molecular life sciences, 72(23), 4445-4460.

Davis, L., & Kuttan, G. (2000). Immunomodulatory activity of Withania somnifera. Journal of ethnopharmacology, 71(1-2), 193–200.

Dhawan, M., Parmar, M., Sharun, K., Tiwari, R., Bilal, M., & Dhama, K. (2021). Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19. J. Appl. Pharm. Sci, 11, 006-013.

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B. J., & Jiang, S. (2009). The spike protein of SARS-CoV—a target for vaccine and therapeutic development. Nature Reviews Microbiology, 7(3), 226-236.

Ge, X. Y., Li, J. L., Yang, X. L., Chmura, A. A., Zhu, G., Epstein, J. H., ... & Shi, Z. L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503(7477), 535-538.

Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J. C., Turner, A. J., ... & Oudit, G. Y. (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation research, 126(10), 1456-1474.

Halliwell, B., &Gutteridge, J. M. (2015). Free radicals in biology and medicine. Oxford University Press, USA.

Kashyap, V. K., Dhasmana, A., Yallapu, M. M., Chauhan, S. C., & Jaggi, M. (2020). Withania somnifera as a potential future drug molecule for COVID-19. Future drug discovery, 2(4), FDD50.

Khanal, P., Chikhale, R., Dey, Y. N., Pasha, I., Chand, S., Gurav, N., Ayyanar, M., Patil, B. M., & Gurav, S. (2021). Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19. Journal of biomolecular structure & dynamics, 1–14.

Khanchandani, N., Shah, P., Kalwani, T., Ardeshna, A., & Dharajiya, D. (2019). Antibacterial and Antifungal Activity of Ashwagandha (Withania somnifera L.): A review. Journal of Drug Delivery and Therapeutics, 9(5-s), 154-161.

Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2021). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of biomolecular structure & dynamics, 39(7), 2659–2672.

Kumar, V., Dhanjal, J. K., Kaul, S. C., Wadhwa, R., & Sundar, D. (2020). Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics, 1-13.

Lal, P., Misra, L., Sangwan, R. S., Tuli, R. (2006). New withanolides from fresh berries of Withania somnifera. Z Naturfors 61, 1143–1147

Mishra, L. C., Singh, B. B., & Dagenais, S. (2000). Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Alternative medicine review, 5(4), 334-346.

Misra, L., Lal, P., Chaurasiya, N. D., Sangwan, R. S., Sinha, S., Tuli, R. (2008). Selective reactivity of 2-mercaptoethanol with 5β,6β-epoxide in steroids from Withania somnifera. Steroids, 73, 245–251.

Misra, L. N., Lal, P., Sangwan, R. S., Sangwan, N. S., Uniyal, G. C., Tuli, R. (2005). Unusually sulfated and oxygenated steroids from Withania somnifera. Phytochemistry, 66, 2702–2707.

Nadkarni, K. M. (1993). Indian Materia Medica. Popular Prakashan Private, Bombay.

Nur–e–Alam, M., Yousaf, M., Qureshi, S., Baig, I., Nasim, S. (2003). A novel dimeric podophyllotoxin–type lignan and a new withanolide from Withania coagulans. Helv Chim Acta, 86, 607–614.

Pandit, M., Latha, N. (2020). In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection.

Parihar, S., & Sharma, D. (2021). A Breif Overview on Vitis vinifera. Sch Acad J Pharm, 12, 231-239.

Parihar, S., & Sharma, D. (2021). A Brief Overview on Crinum Latifolium. IJSR, 10(12), 725-728.

Parihar, S., Chattarpal, Sarswati, Hooda, S., 2022. Moringa oleifera Extract- "A Miracle Tree". Sch Acad J Pharm, 11(1), 1-5.

Parihar, S., Chattarpal., Sharma, D. (2022). Literature review on the list of the plants used in the treatment of lung cancer. WJPPS. 11(1), 2025-2029.

Parihar, S., Sharma, D. (2021). A brief overview on Asparagus racemosus. International Journal of Research and Analytical Reviews. IJRAR, 8(4), 958-975.

Parihar, S., Sharma, D. 2021. Cynodondactylon: A Review of Pharmacological Activities. Sch Acad J Pharm 11, 183-189.

Parihar, S., Sharma, D. 2021. Navagraha (nine planets) plants: the traditional uses and the therapeutic potential of nine sacred plants of india that symbolises nine planets. IJRAR 8 (4), 96-108.

Subbaraju, G. V., Vanisree, M., Rao, C. V., Sivaramakrishna, C., Sridhar, P., Jayaprakasam, B., Nair, M. G. (2006). Ashwagandholide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod., 69,1790–1792

Tuli, R., Sangwan, R. S. (2010). Ashwagandha (Withania somnifera) – a model Indian medicinal plant. Council of Scientific and Industrial Research (CSIR), Govt of India.

Tursunova, R. N., Maslennikova, V. A., Abubakirov, N. K. (1977). Withanolides in the vegetable kingdom. Chem Nat Comp, 13,131-138.

Published
2022-06-01
How to Cite
1.
Parihar S. Anti-viral activity of Withania somnifera phytoconstituents against corona virus (SARS-COV-2) . jpadr [Internet]. 2022Jun.1 [cited 2023Sep.28];3(2):22-6. Available from: http://jpadr.com/index.php/jpadr/article/view/61